Correction: Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis

Christian Gieger | Thomas Meitinger | Andres Metspalu | Joachim Thiery | Melanie Waldenberger | Nicholas G Martin | Nicholas J Wareham | Claudia Langenberg | Cornelia van Duijn | Jennifer Jolley | Peter M Visscher | Denise Anderson | Harm-Jan Westra | Annette Peters | Gérard Waeber | Augusto Rendon | Tonu Esko | Joseph E Powell | Maristella Steri | Serena Sanna | Margaret J Wright | Aaron Isaacs | Lude Franke | Stefania Bandinelli | Michela Traglia | Dale R Nyholt | Clara Camaschella | Lili Milani | Pim van der Harst | Janina S Ried | Andrew C Heath | Pamela A F Madden | Aparna Radhakrishnan | Robert A Scott | Jennie Hui | Martin Gögele | Peter P Pramstaller | Christine Schwienbacher | Najaf Amin | Daniela Toniolo | Zoltan Kutalik | Peter Vollenweider | Fudi Wang | John Beilby | Toshiko Tanaka | S. Bandinelli | D. Hernandez | C. Gieger | M. Waldenberger | P. Visscher | A. Peters | E. Mihailov | L. Kiemeney | Z. Kutalik | W. Ouwehand | J. Jolley | N. Martin | J. Whitfield | J. Hui | J. Beilby | A. Rendon | T. Meitinger | M. Uda | A. Metspalu | T. Esko | G. Montgomery | L. Milani | D. Swinkels | D. Nyholt | N. Wareham | A. Isaacs | J. Ried | H. Westra | C. V. van Duijn | L. Franke | A. Heath | M. Wright | J. Sambrook | B. Benyamin | N. Amin | P. Madden | P. Vollenweider | G. Waeber | J. Luan | R. Scott | C. Langenberg | P. van der Harst | S. Sanna | A. Demirkan | A. Hicks | P. Pramstaller | J. Winkelmann | S. Vermeulen | F. Sweep | I. Pichler | Denise Anderson | N. Verweij | L. Broer | M. Gögele | C. Schwienbacher | D. Toniolo | J. Thiery | M. Traglia | M. Steri | C. Sala | A. Radhakrishnan | C. Camaschella | P. van der Meer | Fudi Wang | K. Oexle | Lambertus A Kiemeney | Niek Verweij | Irene Pichler | Andrew A Hicks | John B Whitfield | Grant W Montgomery | Juliane Winkelmann | Evelin Mihailov | Willem H Ouwehand | Jennifer Sambrook | Toshiko Tanaka | Dorine W Swinkels | Ayse Demirkan | Manuela Uda | Sita H Vermeulen | Konrad Oexle | Linda Broer | Dena Hernandez | Beben Benyamin | Clara Podmore | Jiańan Luan | Peter van der Meer | Jonas Hälldin | Fred C Sweep | Cinzia F Sala | Clara Podmore | J. Powell | Jonas Hälldin | P. van der harst | N. Martin | M. Wright | R. Scott | Michela Traglia | Toshiko Tanaka | C. V. van Duijn | M. Wright | R. Scott

[1]  Toshiko Tanaka,et al.  Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis , 2014, Nature Communications.

[2]  M. Guerreiro,et al.  Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation , 2014, Neurobiology of Aging.

[3]  J. Sinsheimer,et al.  Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin , 2014, Neurobiology of Disease.

[4]  Martina U. Muckenthaler,et al.  A Multi-Scale Model of Hepcidin Promoter Regulation Reveals Factors Controlling Systemic Iron Homeostasis , 2014, PLoS Comput. Biol..

[5]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[6]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[7]  B. Nordestgaard,et al.  Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes , 2013, Diabetes Care.

[8]  Jeffery L. Miller.  Iron deficiency anemia: a common and curable disease. , 2013, Cold Spring Harbor perspectives in medicine.

[9]  Chuong B. Do,et al.  Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study , 2013, PLoS medicine.

[10]  J. Walley,et al.  Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta‐analysis of prospective evidence , 2013, Diabetes/metabolism research and reviews.

[11]  D. McClain,et al.  Iron and diabetes risk. , 2013, Cell metabolism.

[12]  D. Swinkels,et al.  Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. , 2013, Clinical chemistry.

[13]  Lei Wang,et al.  Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. , 2013, The Journal of biological chemistry.

[14]  M. Hentze,et al.  Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to the proliferative Ras/RAF and the nutrient-dependent mTOR signaling pathways Running title: Signaling networks regulating Hepcidin expression , 2013 .

[15]  Christian Gieger,et al.  Seventy-five genetic loci influencing the human red blood cell , 2012, Nature.

[16]  P. Latham,et al.  Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. , 2012, World journal of gastroenterology.

[17]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[18]  W. R. Taylor,et al.  Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[19]  R. Virmani,et al.  Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. , 2012, Journal of the American College of Cardiology.

[20]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[21]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[22]  M. Fornage,et al.  Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.

[23]  N. Mehta.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[24]  J. Connor,et al.  HFE gene variants affect iron in the brain. , 2011, The Journal of nutrition.

[25]  Toshiko Tanaka,et al.  Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. , 2011, Human molecular genetics.

[26]  D. Swinkels,et al.  Mass Spectrometry Analysis of Hepcidin Peptides in Experimental Mouse Models , 2011, PloS one.

[27]  B. Nordestgaard,et al.  Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. , 2011, Clinical chemistry.

[28]  J. Connor,et al.  Mutant HFE H63D Protein Is Associated with Prolonged Endoplasmic Reticulum Stress and Increased Neuronal Vulnerability* , 2011, The Journal of Biological Chemistry.

[29]  D. Swinkels,et al.  Diagnosis and management of hereditary haemochromatosis , 2011, BMJ : British Medical Journal.

[30]  C. Lacombe,et al.  Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. , 2010, Blood.

[31]  Kyle L. Morris,et al.  Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation* , 2010, The Journal of Biological Chemistry.

[32]  Farrukh T Shah,et al.  Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies. , 2010, Hematology/oncology clinics of North America.

[33]  A. Larsson,et al.  Influences of sleep and the circadian rhythm on iron-status indices. , 2010, Clinical biochemistry.

[34]  Inês Barroso,et al.  Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[35]  B. Cherayil.  Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload , 2010, Archivum Immunologiae et Therapiae Experimentalis.

[36]  S. Ohdo,et al.  Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice. , 2010, Cancer research.

[37]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[38]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[39]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[40]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[41]  D. Mutch,et al.  Genetic variation in lipid desaturases and its impact on the development of human disease , 2010, Lipids in Health and Disease.

[42]  E. Rimm,et al.  Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. , 2010, Human molecular genetics.

[43]  T. Assimes,et al.  Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans , 2010, Diabetes.

[44]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[45]  G. Weiss.  Genetic mechanisms and modifying factors in hereditary hemochromatosis , 2010, Nature Reviews Gastroenterology &Hepatology.

[46]  I. Ial,et al.  Nature Communications , 2010, Nature Cell Biology.

[47]  G. Anderson,et al.  Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload , 2009, Hepatology.

[48]  Christian Gieger,et al.  A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.

[49]  Enrico Petretto,et al.  Heritability and Demographic Analyses in the Large Isolated Population of Val Borbera Suggest Advantages in Mapping Complex Traits Genes , 2009, PloS one.

[50]  Gonçalo Abecasis,et al.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.

[51]  Ian H. Frazer,et al.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.

[52]  Christian Gieger,et al.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.

[53]  H. Tsukamoto,et al.  Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. , 2009, Cell metabolism.

[54]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[55]  J. Beard,et al.  Diurnal cycle influences peripheral and brain iron levels in mice. , 2009, Journal of applied physiology.

[56]  Joan E Bailey-Wilson,et al.  Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies , 2008, BMC Genomics.

[57]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[58]  D. English,et al.  Iron-overload-related disease in HFE hereditary hemochromatosis. , 2008, The New England journal of medicine.

[59]  G. Ramm,et al.  Role of iron in hepatic fibrosis: one piece in the puzzle. , 2007, World journal of gastroenterology.

[60]  B. Ames,et al.  An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. , 2007, The American journal of clinical nutrition.

[61]  H. Tamary,et al.  Hypocholesterolemia in chronic anemias with increased erythropoietic activity , 2007, American journal of hematology.

[62]  M. Oudkerk,et al.  Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. , 2007, Magnetic resonance imaging.

[63]  N. Andrews,et al.  Hereditary Hemochromatosis Protein, HFE, Interaction with Transferrin Receptor 2 Suggests a Molecular Mechanism for Mammalian Iron Sensing* , 2006, Journal of Biological Chemistry.

[64]  E. Harris,et al.  Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force , 2006, Annals of Internal Medicine.

[65]  D. Swinkels,et al.  Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. , 2006, Clinical Chemistry.

[66]  E. Thomson,et al.  Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.

[67]  W. Stremmel,et al.  Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. , 2005, Gastroenterology.

[68]  C. Férec,et al.  Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. , 2003, American journal of epidemiology.

[69]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[70]  D. Duffy,et al.  Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. , 2000, American journal of human genetics.

[71]  J. Cook,et al.  Serum Transferrin Receptor : A Quantitative Measure of Tissue Iron Deficiency , 2003 .